GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

9478	Companies
185496	Keywords
117875	Articles
99351	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 06/10/2024 at 23:22, 1 year 5 months ago

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine
GENFIT franchit une étape historique avec l'approbation accélérée d'Iqirvo par la FDA américaine pour la Cholangite Biliaire Primitive en partenariat avec Ipsen

Approbation Accélérée Cholangite Biliaire Primitive GENFIT Iqirvo FDA Américaine
PRESS RELEASE

published on 06/10/2024 at 23:22, 1 year 5 months ago

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
GENFIT achieves historic milestone with U.S. FDA accelerated approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis. Elafibranor tablets approved as first-in-class treatment, marking a significant development in rare liver disease treatment landscape

Primary Biliary Cholangitis GENFIT Ipsen Iqirvo FDA Accelerated Approval
BRIEF

published on 05/29/2024 at 22:15, 1 year 6 months ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024

Research Collaboration GENFIT ACLF EASL Congress Liver Disease
BRIEF

published on 05/29/2024 at 22:15, 1 year 6 months ago

GENFIT présentera ses dernières recherches sur l'ACLF au congrès EASL™ 2024

Collaboration En Recherche GENFIT ACLF Congrès De L'EASL Maladie Du Foie
PRESS RELEASE

published on 05/29/2024 at 22:10, 1 year 6 months ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
GENFIT to present latest ACLF research at EASL Congress™ 2024, showcasing collaborative efforts with EF CLIF to advance understanding of ACLF pathophysiology and treatment approaches

Liver Diseases GENFIT ACLF Research EASL Congress 2024 EF CLIF Partnership
PRESS RELEASE

published on 05/29/2024 at 22:10, 1 year 6 months ago

GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024
GENFIT présente ses avancées dans l'ACLF au congrès EASL 2024, détaillant un partenariat de recherche avec l'EF CLIF et des programmes de recherche dans l'ACLF, mettant en avant le potentiel de transformation du traitement

Recherche Traitement GENFIT ACLF EASL
BRIEF

published on 05/14/2024 at 22:15, 1 year 6 months ago

GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025

Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF

published on 05/14/2024 at 22:15, 1 year 6 months ago

GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025

Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
PRESS RELEASE

published on 05/14/2024 at 22:10, 1 year 6 months ago

GENFIT Reports First Quarter 2024 Financial Information
GENFIT reports Q1 2024 financial information showing cash position of €74.0 million and revenues of €1.1 million. Company expects cash to fund operations until Q4 2025

Financial Information Revenues Cash Position Q1 2024 GENFIT
PRESS RELEASE

published on 05/14/2024 at 22:10, 1 year 6 months ago

GENFIT : Information financière du premier trimestre 2024
GENFIT annonce sa situation de trésorerie au 31 mars 2024 et son chiffre d'affaires du premier trimestre 2024, avec des revenus en baisse par rapport à 2023

Chiffre D'affaires Biopharmaceutique Trésorerie Maladies Rares GENFIT

Accesswire

Published on 12/05/2025 at 17:00, 10 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 25 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 25 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour 35 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 10 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 45 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 10 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 59 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 59 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 12 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 8 hours 25 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 8 hours 25 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE